Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic StrokeYuanyuan Zeng, Chao Jiang, Kevin L. Wallace et al.|Oxidative Medicine and Cellular Longevity|2023Cited by 4